Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
109.8 USD | -1.93% | -0.89% | -10.80% |
13/05 | US reclassification could drive fresh research funding into pot sector | RE |
07/05 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.80% | 706.11Cr | |
+30.87% | 59TCr | |
-3.41% | 36TCr | |
+19.16% | 33TCr | |
+5.24% | 29TCr | |
+15.25% | 24TCr | |
+9.99% | 21TCr | |
-6.91% | 20TCr | |
+9.87% | 17TCr | |
-0.61% | 16TCr |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- RBC Lifts Jazz Pharmaceuticals' Price Target to $203 From $202, Keeps Outperform Rating